ARTICLE | Management Tracks
Plus: van Tilburg takes the helm at Renovaro and updates from Medicilon, Applied, Neurocentrx and more
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
December 31, 2024 11:39 PM UTC
As San Diego-based Epirium Bio Inc. becomes a clinical company, it is elevating COO Alex Casdin to CEO on Jan. 1, succeeding Russell Cox, who will become executive chair. Epirium said FDA has cleared an IND for MF-300, an orally administered, 15-hydroxyprostaglandin dehydrogenase inhibitor to treat sarcopenia.
Cancer diagnostics and therapeutics company Renovaro Inc. (NASDAQ:RENB) named Chairman Maurice van Tilburg CEO of subsidiary Gedi Cube BV. Van Tilburg recently retired as the director of the Dutch National Growth Fund…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654553/casdin-to-succeed-cox-at-epirium